KRYS logo

Krystal Biotech (KRYS) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$344.87 M
-$13.46 M-3.76%

December 31, 2024


Summary


Performance

KRYS Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKRYSbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$344.87 M
-$29.10 M-7.78%

December 31, 2024


Summary


Performance

KRYS Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKRYSbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

KRYS Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.8%-3.9%
3 y3 years+1.1%+113.0%
5 y5 years+83.9%+113.0%

KRYS Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-3.8%+113.0%-7.8%+145.0%
5 y5-year-3.8%+113.0%-14.3%+145.0%
alltimeall time-3.8%>+9999.0%-14.3%>+9999.0%

Krystal Biotech Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$344.87 M(-3.8%)
$344.87 M(-7.8%)
Sep 2024
-
$373.97 M(+8.1%)
Jun 2024
-
$345.79 M(-3.7%)
Mar 2024
-
$359.01 M(+0.2%)
Dec 2023
$358.33 M(+121.3%)
$358.33 M(-4.0%)
Sep 2023
-
$373.24 M(+35.3%)
Jun 2023
-
$275.88 M(+96.0%)
Mar 2023
-
$140.75 M(-13.1%)
Dec 2022
$161.90 M(-52.6%)
$161.90 M(-13.1%)
Sep 2022
-
$186.41 M(-14.8%)
Jun 2022
-
$218.72 M(-18.8%)
Mar 2022
-
$269.30 M(-21.1%)
Dec 2021
$341.25 M(+27.2%)
$341.25 M(+19.1%)
Sep 2021
-
$286.61 M(-13.0%)
Jun 2021
-
$329.53 M(-18.1%)
Mar 2021
-
$402.17 M(+49.9%)
DateAnnualQuarterly
Dec 2020
$268.27 M(+43.1%)
$268.27 M(-5.0%)
Sep 2020
-
$282.37 M(-3.2%)
Jun 2020
-
$291.68 M(+61.8%)
Mar 2020
-
$180.22 M(-3.9%)
Dec 2019
$187.51 M(+80.9%)
$187.51 M(-3.7%)
Sep 2019
-
$194.81 M(+4.4%)
Jun 2019
-
$186.59 M(+90.4%)
Mar 2019
-
$98.01 M(-5.5%)
Dec 2018
$103.67 M(+109.1%)
$103.67 M(+122.1%)
Sep 2018
-
$46.67 M(+11.6%)
Jun 2018
-
$41.81 M(-11.5%)
Mar 2018
-
$47.23 M(-4.8%)
Dec 2017
$49.59 M(+2478.8%)
$49.59 M(-5.7%)
Sep 2017
-
$52.57 M(+1394.3%)
Jun 2017
-
$3.52 M(+82.9%)
Dec 2016
$1.92 M
$1.92 M

FAQ

  • What is Krystal Biotech annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Krystal Biotech?
  • What is Krystal Biotech annual cash & cash equivalents year-on-year change?
  • What is Krystal Biotech quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Krystal Biotech?
  • What is Krystal Biotech quarterly cash and cash equivalents year-on-year change?

What is Krystal Biotech annual cash & cash equivalents?

The current annual cash & cash equivalents of KRYS is $344.87 M

What is the all time high annual cash & cash equivalents for Krystal Biotech?

Krystal Biotech all-time high annual cash & cash equivalents is $358.33 M

What is Krystal Biotech annual cash & cash equivalents year-on-year change?

Over the past year, KRYS annual cash & cash equivalents has changed by -$13.46 M (-3.76%)

What is Krystal Biotech quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of KRYS is $344.87 M

What is the all time high quarterly cash and cash equivalents for Krystal Biotech?

Krystal Biotech all-time high quarterly cash and cash equivalents is $402.17 M

What is Krystal Biotech quarterly cash and cash equivalents year-on-year change?

Over the past year, KRYS quarterly cash and cash equivalents has changed by -$14.14 M (-3.94%)